ANI Pharmaceuticals | ANIP - Loan Capital


ANI Pharmaceuticals reported $280.15M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
AbbVie USD 64.53B 5.59B Mar/2026
ANI Pharmaceuticals USD 280.15M 5.84M Jun/2026
Aurora Cannabis CAD 18.13M 15.07M Mar/2026
Canopy Growth CAD 217.12M 7.87M Mar/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Heron Therapeutics USD 140.64M 975K Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Omeros USD 403.72M 27.2M Jun/2024
Perrigo USD 3.28B 337.7M Jun/2026
Sun Pharmaceuticals INR 3.93B 309.9M Mar/2026
Teva Pharmaceutical Industries USD 12.09B 1.92B Jun/2026